Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Protalix BioTherapeutics, Inc. (DE) Common Stock
(NY:
PLX
)
2.525
-0.035 (-1.37%)
Delayed Quote
Updated: 3:18 PM EST, Nov 3, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Protalix BioTherapeutics, Inc. (DE) Common Stock
< Previous
1
2
3
4
5
Next >
Protalix (PLX) Q2 2026 Earnings Call Transcript
↗
August 19, 2026
Elfabrio sales surge drives $19.9M quarterly revenue and $22.1M H1 net income.
Via
The Motley Fool
Topics
Earnings
Intellectual Property
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
March 18, 2026
Via
Chartmill
Discover the top movers in Wednesday's pre-market session.
↗
March 18, 2026
Via
Chartmill
PLX Shares Jump 13% On EMA Committee’s Turnaround On New Dosing Regimen For Fabry Disease Therapy
↗
January 30, 2026
Via
Stocktwits
Earnings Scheduled For November 13, 2025
↗
November 13, 2025
Via
Benzinga
Protalix BioTherapeutics Stock Tumbled 28% Today: Why The Latest CHMP Opinion Is Sparking Concerns Among Investors?
↗
October 17, 2025
Via
Stocktwits
Earnings Scheduled For August 14, 2025
↗
August 14, 2025
Via
Benzinga
Preview: Protalix BioTherapeutics's Earnings
↗
August 13, 2025
Via
Benzinga
Preview: Protalix BioTherapeutics's Earnings
↗
November 12, 2025
Via
Benzinga
PLX Investors Have Opportunity to Join Protalix BioTherapeutics, Inc. Fraud Investigation with the Schall Law Firm
November 05, 2025
From
Schall Law
Via
GlobeNewswire
PLX Investors Have Opportunity to Join Protalix BioTherapeutics, Inc. Fraud Investigation with the Schall Law Firm
October 31, 2025
From
The Schall Law Firm
Via
Business Wire
Top stock movements in today's session.
↗
October 17, 2025
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
Why Is Protalix BioTherapeutics Stock Falling On Friday?
↗
October 17, 2025
EMA issues a negative opinion on Protalix and Chiesi's Elfabrio revised dosing for Fabry disease, citing insufficient data to confirm efficacy.
Via
Benzinga
Which stocks are gapping on Friday?
↗
October 17, 2025
Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
October 17, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
October 02, 2025
Via
Benzinga
Presenting at the Investor Summit Q3 2025 on September 16; Watch the Live Stream for Free
September 16, 2025
Via
ACCESS Newswire
Protalix BioTherapeutics to Present at Investor Summit Virtual
September 11, 2025
Via
ACCESS Newswire
Protalix Revenue Jumps 16 Percent in Q2
↗
August 14, 2025
Via
The Motley Fool
Top movers in Friday's session
↗
May 09, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Keep an eye on the top gainers and losers in Friday's session.
↗
May 09, 2025
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
The market is filled with gapping stocks in Friday's session.
↗
May 09, 2025
The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via
Chartmill
Wondering what's happening in today's pre-market session?
↗
May 09, 2025
Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
May 09, 2025
Via
Benzinga
Earnings Scheduled For May 9, 2025
↗
May 09, 2025
Via
Benzinga
Uncovering Potential: Protalix BioTherapeutics's Earnings Preview
↗
May 08, 2025
Via
Benzinga
Regulus Downgraded By Analysts After $1.7B Novartis Buyout Offer — Street Sees Limited Upside Ahead
↗
May 01, 2025
Regulus Therapeutics shares surged after Novartis announced a $1.7 billion acquisition, but analysts downgraded the stock citing limited upside. Retail sentiment remained bullish, with speculation of a...
Via
Stocktwits
Topics
Stocks
Evaluating PROTALIX BIOTHERAPEUTICS INC (NYSEARCA:PLX) using Mark Minervini’s winning stock formula
↗
April 21, 2025
A fundamental and technical analysis of (NYSEARCA:PLX): PROTALIX BIOTHERAPEUTICS INC (NYSEARCA:PLX) may be suited for high growth investing, we'll explore why in this article.
Via
Chartmill
Does PROTALIX BIOTHERAPEUTICS INC (NYSEARCA:PLX) show the characteristics of a Minervini super stock?
↗
March 22, 2025
A fundamental and technical analysis of (NYSEARCA:PLX): Is PROTALIX BIOTHERAPEUTICS INC (NYSEARCA:PLX) suited for high growth investing?
Via
Chartmill
iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025
March 21, 2025
Via
ACCESS Newswire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
